Antithrombotic therapy has no beneficial effect in conservative treatment of spontaneous isolated superior mesenteric arterial dissection
| Autor: | Ho Kyun Lee, Soo Jin Choi, Young Sup Yoo |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
medicine.medical_specialty
030204 cardiovascular system & hematology 03 medical and health sciences 0302 clinical medicine Spontaneous isolated superior mesenteric artery dissection medicine.artery Antithrombotic medicine 030212 general & internal medicine Superior mesenteric artery Arterial dissection business.industry Antithrombotic agent Clinical course Warfarin medicine.disease Remodeling Surgery Conservative treatment Dissection Original Article business Dyslipidemia medicine.drug |
| Zdroj: | Annals of Surgical Treatment and Research |
| ISSN: | 2288-6796 2288-6575 |
| DOI: | 10.4174/astr.2021.100.3.166 |
| Popis: | Purpose Initial conservative treatment with selective endovascular or surgical intervention has shown successful outcomes in the treatment of spontaneous isolated superior mesenteric artery dissection (SISMAD). However, the benefits of antithrombotic therapy as a part of conservative treatment have not been clarified. This study aimed to investigate the clinical course of SISMAD patients and determine differences in clinical outcomes between the antithrombotic and no-antithrombotic groups. Methods We retrospectively reviewed 79 cases of SISMAD that were treated conservatively from January 2004 to December 2019 at Chonnam National University Hospital. Clinical outcomes, including the length of hospital stay, pain resolution time, image remodeling, and maximal remodeling time, were compared between the antithrombotic and no-antithrombotic groups. Results There were 30 patients in the no-antithrombotic group and 49 patients in the antithrombotic group. There was no significant difference in clinical characteristics between the 2 groups, except for dyslipidemia (P = 0.011). The follow-up period (32.6 months vs. 14.6 months, P = 0.009) and imaging follow-up period (31.6 months vs. 13.9 months, P = 0.011) were longer in the antithrombotic group than in the no-antithrombotic group. The length of hospital stay (5.1 days vs. 7.7 days, P = 0.002) was significantly shorter in the no-antithrombotic group than in the antithrombotic group because patients in the antithrombotic group required longer hospitalization for warfarin titration. Conclusion In patients with SISMAD, conservative treatment without antithrombotic therapy may have clinical benefits such as decreased length of hospital stay compared with conservative treatment with antithrombotic therapy. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|